A recent report published by Infinium Global Research on
tuberculosis drugs market provides in-depth analysis of segments and
sub-segments in global as well as regional tuberculosis drugs market. The study
also highlights the impact of drivers, restraints and macro indicators on the
global and regional tuberculosis drugs market over the short term as well as
long term. The report is a comprehensive presentation of trends, forecast and
dollar values of the global tuberculosis drugs market. According to the report the
global tuberculosis drugs market is projected to grow at a CAGR of 4.8% over
the forecast period of 2018-2024.
The Tuberculosis is the infectious disease caused by the Mycobacterium tuberculosis bacteria. This Mycobacterium tuberculosis bacteria can be transmitted into the air by the people are infected with TB through the coughing, sneezing or spitting. TB generally affects the lungs but it may affect the other part of the body. According to WHO, Tuberculosis is one of the top 10 causes of death worldwide and in 2016, 10.4 million people fell ill with TB, and 1.7 million died from the disease (including 0.4 million among people with HIV). Over 95% of TB deaths occur in low- and middle-income countries. All over the world, the occurrence of TB is rising to vary rapidly which drive the growth of TB Diagnostic Market
Rapidly growing occurrence of multi-drug
resistant tuberculosis is the primary factor driving the growth of tuberculosis
drugs market. In addition, some major organizations such as Unitaid, WHO,
UNICEF, and TB Alliance are working together to develop an effective drug to treat
the Tuberculosis and fulfill the demand for drugs. However, the drugs are limited
as compared to the demand that may hamper the market growth. Moreover, the
numerous governments of various emerging countries are lunches various program
with the help of major healthcare organizations to prevent or overcome the Tuberculosis
are projected to create more opportunities in the tuberculosis drugs market
over the forecast period.
Geographically, Asia-Pacific
dominates the market of TB Diagnostic. In this region, India accounts for the
largest share of the TB Diagnostic market. According to the TB Report 2017
released by the world health organization (WHO), India continues to have the
highest number of tuberculosis cases in the world. The undeveloped healthcare
infrastructure in the emerging countries contributes to the market growth of TB
Diagnostic in the Asia Pacific region. The countries such as China made a
partnership with the Bill & Melinda Gates Foundation to improve treatment
and detection of TB which is expected to accelerate the market growth of Tuberculosis
drug market in this region.
Segment Covered
The report on global tuberculosis drugs market covers segments
such as disease type, drug class, and distribution channel. On the basis of
disease type, the global tuberculosis drugs market is categorized into active TB
and latent TB. On the basis of drug class, the global tuberculosis drugs market
is categorized into first-line anti-TB drugs, second-line anti-TB drugs, and
combination drugs.
Geographic Coverage
The report provides regional analysis covering geographies such
as North America, Europe, Asia-Pacific, and Rest of the World. In this section, the key trends and market size for each geography are provided over the period
of 2016-2024. The countries covered in the North America region include the
U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India,
South Korea, Malaysia, and among others. Moreover, Germany, U.K., France,
Spain and Rest of Europe are included in the European region. The U.S. drives
the growth in the North America region as it is the largest market in the
region. The Asia-pacific region offers a substantial potential for the market
growth owing to rapid growth in markets such as India and China. The APAC
region is projected to experience growth at a CAGR of x.x% over the period of
2018-2024.
Companies Profiled:
The report provides profiles of the companies in the global
tuberculosis drugs market such as Pfizer, Otsuka Novel Products, Lupin, Sanofi,
Novartis AG, Merck & Co., Bayer AG, AstraZeneca, Sandoz International GmbH
and Cipla Ltd.
Report Highlights:
The report provides deep insights on demand forecasts, market
trends, and micro and macro indicators. In addition, this report provides insights
into the factors that are driving and restraining the global tuberculosis drugs
market. Moreover, IGR-Growth Matrix analysis given in the report brings an
insight into the investment areas that existing or new market players can
consider. The report provides insights into the market using analytical tools
such as Porter's five forces analysis and DRO analysis of tuberculosis drugs
market. Moreover, the study highlights current market trends and provides
forecast from 2018-2024. We also have highlighted future trends in the
tuberculosis drugs market that will impact the demand during the forecast
period. Moreover, the competitive analysis given in each regional market brings
an insight on the market share of the leading players. This report will help
manufacturers, suppliers, and distributors of the tuberculosis drugs market to
understand the present and future trends in this market and formulate their
strategies accordingly.
Please Choose One of them.